Livsmed Inc (KOSDAQ:491000)
South Korea
· Delayed Price · Currency is KRW
83,200
-8,100 (-8.87%)
At close: Mar 9, 2026
Livsmed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.23 | 0.21 | -0.06 | -0.04 |
| Net Debt / Equity Ratio | -0.01 | -0.21 | 0.39 | 0.05 |
| Net Debt / EBITDA Ratio | 0.02 | 0.34 | 1.52 | 0.47 |
| Net Debt / FCF Ratio | 0.01 | 0.26 | 1.29 | 0.42 |
| Asset Turnover | - | 0.48 | 0.39 | - |
| Inventory Turnover | - | 3.11 | 2.32 | - |
| Quick Ratio | 2.63 | 3.53 | 0.33 | 0.10 |
| Current Ratio | 3.52 | 4.21 | 0.36 | 0.12 |
| Return on Assets (ROA) | - | -29.15% | -33.88% | - |
| Return on Capital Employed (ROCE) | -38.30% | -59.80% | 27.50% | 11.00% |
| Buyback Yield / Dilution | -47.30% | -17.94% | -10.39% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.